zinc sulfate has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguilera-Rodríguez, R; Almaguer Mederos, LE; Batista, IH; Canales-Ochoa, N; García-Rodríguez, JC; Gotay, DA; Laffita Mesa, JM; López-Hernandez, OD; Novas, AJ; Polanco, ID; Porto-Verdecia, M; Pupo, NR; Rodríguez-Chanfrau, J; Rodríguez-Díaz, JC; Rodríguez-Labrada, R; Sánchez-Cruz, G; Triana, CG; Velázquez-Pérez, L | 1 |
1 trial(s) available for zinc sulfate and Autosomal Dominant Cerebellar Ataxia, Type II
Article | Year |
---|---|
Oral zinc sulphate supplementation for six months in SCA2 patients: a randomized, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Catalase; Cuba; Dietary Supplements; Double-Blind Method; Humans; Malondialdehyde; Middle Aged; Placebos; Saccades; Spinocerebellar Ataxias; Superoxide Dismutase; Treatment Outcome; Young Adult; Zinc; Zinc Sulfate | 2011 |